OKUR Onkure Therapeutics, Inc.

Fundamentals / CIK 0001637715 / USD

Onkure Therapeutics, Inc. reported $167.1M in total assets and a net loss of $61.85M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open OKUR in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$0$0$0-$55.65MFY 2020 Net Income: -$19.46M2020FY 2021 Net Income: -$39.77M2021FY 2022 Net Income: -$51.95M2022FY 2023 Net Income: -$35.31M2023FY 2024 Revenue: $0FY 2024 Net Income: -$52.67M2024FY 2025 Net Income: -$59.52M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- $0 -- -- -- --
Research & Development $48.26M $43.80M $32.12M $37.70M $28.17M $15.94M
Total Operating Expenses $62.95M $54.39M $36.93M $53.85M $39.82M $19.55M
Operating Income -$62.95M -$54.39M -$36.93M -$53.85M -$39.82M -$19.55M
EBITDA -$62.50M -$53.93M -$36.52M -$53.76M -$39.77M -$19.52M
Interest Income $3.44M $2.01M $1.62M -- -- --
Income Before Tax -- -- -$77.39M -$51.95M -$39.77M -$19.46M
Income Tax Expense $0 $0 $0 $0 $0 $0
Net Income -$59.52M -$52.67M -$35.31M -$51.95M -$39.77M -$19.46M
Basic EPS -$4.40 -$15.28 -$124.41 -$21.20 -$21.90 -$96.00
Diluted EPS -$4.40 -$15.28 -$124.41 -$21.20 -$21.90 -$96.00
Basic Shares Outstanding 13.5M 3.4M 283.8K 2.4M 1.8M 202.8K
Diluted Shares Outstanding 13.5M 3.4M 283.8K 2.4M 1.8M 202.8K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $15.06M $12.61M $11.71M $10.72M $11.91M $12.61M $13.01M $14.36M
Total Operating Expenses $19.35M $16.90M $15.62M $14.12M $15.50M $16.32M $17.00M $18.70M
Operating Income -$19.35M -$16.90M -$15.62M -$14.12M -$15.50M -$16.32M -$17.00M -$18.70M
EBITDA -$19.30M -$16.81M -$15.51M -$14.02M -$15.39M -$16.21M -$16.88M -$18.58M
Interest Income $1.50M $1.55M $458K $628K $804K $934K $1.07M $1.31M
Net Income -$17.85M -$15.35M -$15.16M -$13.50M -$14.70M -$15.39M -$15.93M -$17.44M
Basic EPS -$0.36 -$0.31 -$1.11 -- -$1.09 -$1.14 -$1.19 --
Diluted EPS -$0.36 -$0.31 -$1.11 -- -$1.09 -$1.14 -$1.19 --
Basic Shares Outstanding 49.9M 49.9M 13.7M -- 13.5M 13.5M 13.4M --
Diluted Shares Outstanding 49.9M 49.9M 13.7M -- 13.5M 13.5M 13.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $59.05M $110.8M $29.88M $19.93M $124.7M $53.61M
Short-Term Investments $0 -- $75.33M $81.25M $23.01M --
Cash & Short-Term Investments $59.05M $110.8M $105.2M $101.2M $147.7M $53.61M
Total Current Assets $60.84M $113.0M $33.77M $106.4M $153.7M $55.02M
Property, Plant & Equipment, Net $618K $1.02M $1.43M $453K $212K $69K
Other Non-Current Assets $273K $109K $58K $84K $78K $127K
Total Non-Current Assets $1.28M $1.90M $1.97M $1.83M $290K $196K
Total Assets $62.12M $114.9M $35.73M $108.2M $154.0M $55.22M
Accounts Payable $1.43M $2.97M $3.42M $1.89M $2.02M $908K
Total Current Liabilities $5.92M $10.53M $7.29M $7.12M $6.20M $4.58M
Other Non-Current Liabilities $12K -- -- -- $167K --
Total Non-Current Liabilities $12K $549K $466K $1.09M $611K $36K
Total Liabilities $5.93M $11.08M $7.75M $8.21M $6.81M $4.62M
Total Debt (incl. Leases) $549K $1.08M $674K $1.46M -- --
Common Stock -- -- $0 $3.0K $3.0K --
Retained Earnings -$214.2M -$154.7M -$102.1M -$136.7M -$84.73M -$44.96M
Accumulated Other Comp. Income $0 -- $8.0K -$43K $34K --
Total Stockholders' Equity $56.18M $103.8M -$101.8M -$54.42M $147.2M -$42.12M
Total Equity $56.18M $103.8M -$101.8M -$54.42M $147.2M -$42.12M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $151.4M $166.5M $192.1M $59.05M $70.33M $83.37M $96.66M $110.8M
Short-Term Investments $11.86M $9.88M -- $0 -- -- -- --
Cash & Short-Term Investments $163.3M $176.4M $192.1M $59.05M $70.33M $83.37M $96.66M $110.8M
Total Current Assets $165.6M $177.7M $197.5M $60.84M $71.53M $84.55M $98.17M $113.0M
Property, Plant & Equipment, Net $414K $435K $519K $618K $720K $821K $925K $1.02M
Other Non-Current Assets $409K $401K $405K $273K $104K $116K $109K $109K
Total Non-Current Assets $1.48M $1.68M $1.21M $1.28M $1.31M $1.52M $1.71M $1.90M
Total Assets $167.1M $179.4M $198.7M $62.12M $72.83M $86.07M $99.88M $114.9M
Accounts Payable $2.31M $2.00M $11.02M $1.43M $1.29M $2.38M $2.34M $2.97M
Total Current Liabilities $8.79M $6.64M $14.33M $5.92M $6.25M $7.60M $8.79M $10.53M
Other Non-Current Liabilities $12K $12K $12K $12K $40K $40K $40K --
Total Non-Current Liabilities $551K $602K $12K $12K $160K $307K $449K $549K
Total Liabilities $9.34M $7.25M $14.34M $5.93M $6.41M $7.90M $9.23M $11.08M
Total Debt (incl. Leases) $790K $926K $409K $549K $687K $823K $955K $1.08M
Retained Earnings -$262.6M -$244.7M -$229.4M -$214.2M -$200.7M -$186.0M -$170.6M -$154.7M
Accumulated Other Comp. Income -$30K -$13K -- $0 -- -- -- --
Total Stockholders' Equity $157.7M $172.1M $184.4M $56.18M $66.43M $78.17M $90.65M $103.8M
Total Equity $157.7M $172.1M $184.4M $56.18M $66.43M $78.17M $90.65M $103.8M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$59.52M -$52.67M -$35.31M -$51.95M -$39.77M -$19.46M
Depreciation & Amortization $447K $459K $417K $88K $50K $37K
Stock-Based Compensation $11.63M $4.53M $199K $4.32M $3.89M $393K
Operating Cash Flow -$51.83M -$51.12M -$34.55M -$47.36M -$37.98M -$18.54M
Capital Expenditure -$46K -$52K -$246K -$346K -$198K -$24K
Free Cash Flow -$51.87M -$51.17M -$34.79M -$47.71M -$38.18M -$18.56M
Purchases of Investments -- -- -$231.3M -$101.6M -$31.41M --
Investing Cash Flow -$46K $15.87M -$246K -$57.84M -$23.38M $7.38M
Common Stock Issued -- -- -- $193K $84.61M --
Share Repurchases -- -- -$4.40M -- -- --
Financing Cash Flow $163K $116.1M $53.12M $471K $132.4M $47.27M
Net Change in Cash -$51.71M $80.89M $18.33M -$104.7M $71.05M $36.11M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$17.85M -$15.35M -$15.16M -$13.50M -$14.70M -$15.39M -$15.93M -$17.44M
Depreciation & Amortization $53K $87K $104K $104K $108K $117K $118K $116K
Stock-Based Compensation $3.49M $3.05M $2.78M $3.02M $2.96M $2.91M $2.75M $2.53M
Operating Cash Flow -$13.08M -$10.35M -$12.94M -$11.51M -$13.04M -$13.27M -$14.01M -$23.35M
Capital Expenditure -$32K -$3.0K -$5.0K -$9.0K -$6.0K -$13K -$18K -$15K
Free Cash Flow -$13.11M -$10.36M -$12.94M -$11.52M -$13.04M -$13.29M -$14.02M -$23.37M
Investing Cash Flow -$1.97M -$9.87M -$5.0K -$9.0K -$6.0K -$13K -$18K $15.91M
Financing Cash Flow -$8.0K -$5.38M $146.0M $240K $0 $0 -$77K $110.2M
Net Change in Cash -$15.06M -$25.60M $133.1M -$11.28M -$13.04M -$13.29M -$14.10M $102.8M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -105.9% -50.7% -- -- -27.0% --
Return on Assets (ROA) -95.8% -45.8% -98.8% -48.0% -25.8% -35.2%
Current Ratio 10.28x 10.73x 4.64x 14.93x 24.79x 12.01x
Quick Ratio 9.97x 10.52x 14.44x 14.20x 23.81x 11.71x
Debt to Equity 0.01x 0.01x -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -39.2% -34.1% -31.9% -105.9% -95.5% -77.2% -65.2% -50.7%
Return on Assets (ROA) -37.0% -32.7% -29.6% -95.8% -87.1% -70.1% -59.1% -45.8%
Current Ratio 18.84x 26.75x 13.78x 10.28x 11.45x 11.13x 11.17x 10.73x
Quick Ratio 18.58x 26.55x 13.41x 9.97x 11.26x 10.97x 11.00x 10.52x
Debt to Equity 0.01x 0.01x 0.00x 0.01x 0.01x 0.01x 0.01x 0.01x
Operating Income Growth (YoY) -- -- -- -- -- -- -- -188.6%
Net Income Growth (YoY) -- -- -- -- -- -- -- -194.2%
Operating Cash Flow Growth (YoY) -- -- -- -- -- -- -- -348.9%
Free Cash Flow Growth (YoY) -- -- -- -- -- -- -- -350.4%
Source: SEC EDGAR CompanyFacts (CIK 0001637715) · from March 31, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:47 UTC · Open in terminal